Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
about
Linkers Having a Crucial Role in Antibody-Drug ConjugatesAntibody-drug conjugates as novel anti-cancer chemotherapeuticsNovel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierAntibody drug conjugates: design and selection of linker, payload and conjugation chemistryStability analysis of an inline peptide-based conjugate for metal delivery: nickel(II)-claMP Tag epidermal growth factor as a model system.Effects of localized interactions and surface properties on stability of protein-based therapeutics.Computational Construction of Antibody-Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable LinkerNative mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate.Chemically programmed antibodies.Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.Detection and quantitation of succinimide in intact protein via hydrazine trapping and chemical derivatization.Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugatesCurrent challenges in peptide-based drug discovery.Challenges and new frontiers in analytical characterization of antibody-drug conjugates.An anti-EGFR × cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations.
P2860
Q26752763-D5C52DA1-2930-4841-9D80-3BFDF02DA1F9Q26800175-2FC46F3B-2B41-4B3F-A5A0-4A812B01557FQ28542642-EC1E963D-8656-4491-98C0-2F1DC9A1B58DQ28544658-ADA38F36-C6FA-4F6D-BD4D-B40BA795A395Q30366709-F626E69F-E960-4FC3-81DC-270FC1F86668Q30395368-EEA27D70-A771-486A-8C6E-7C00AF9A61DCQ34663010-92917602-2BDC-4DF4-8BEA-26D23FA03D64Q35946005-01D243A4-EB97-4295-92A2-E176361F7FF2Q37327321-CB2FDFFB-0FB1-474B-A142-C1F2DF295BD6Q38196060-ABEB1A57-C5C2-42D5-9AD3-0D4294F3DAE0Q38489049-B41825A3-0CF1-4F71-9802-2AAF2BBD1903Q38665164-58DB137C-A2CB-4623-9D37-19CBDBE21423Q41833694-0F03CBD5-2054-4CCD-8BD9-F9E8CD25BCE8Q42646020-5C5E272D-F2DE-4331-A816-01C2735C28ABQ42778271-9F259D8B-E56E-441F-8F0F-B4EC53ECD55AQ52401505-661559EC-1DE6-4F9F-B6E8-57D28A656BFAQ55439903-C9A55A29-41DD-422D-95B7-978C5C13DA8C
P2860
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
@en
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
@nl
type
label
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
@en
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
@nl
prefLabel
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
@en
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.
@nl
P2093
P2860
P356
P1476
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates
@en
P2093
Janet L Wolfe
Nicholas J Boylan
Robert J Proos
Thomas J Tolbert
P2860
P304
P356
10.1021/BC4000564
P577
2013-05-31T00:00:00Z